To advance the development, evaluation, and predictive modeling of levonorgestrel intrauterine systems (LNG-iuss) by integrating accelerated testing, real-time release studies, microstructural…
Active Definitive Contract Awarded Last action
- Contract number
- 75F40126C00059
- Awardee
-
University Of Connecticut UEI WNTPS995QBM7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $511,219
Award facts
- Opportunity
-
- FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Special Notice · FDABAA2600123 · Posted Nov 21, 2025
- Contract value 65% obligated
-
- $511,219.00 Current, with exercised options
- $789,844.00 Potential, with all options
- Completion date 2% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 257 offers Basic Research
- Pricing
- Firm Fixed Price
- Place of performance
- Takoma Park, MD 20901, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $789,844 definitive contract to the University of Connecticut on September 30, 2026, to advance development, evaluation, and predictive modeling of levonorgestrel intrauterine systems through accelerated testing, real-time release studies, microstructural analysis, and AI/ML-driven modeling approaches.
The award derives from the FY26 FDA Broad Agency Announcement for Advanced Research and Development of Regulatory Science, a Special Notice posted November 21, 2025, soliciting basic and applied research supporting regulatory science and innovation across FDA-regulated domains. The contract employs firm fixed price as the pricing mechanism and carries an ultimate completion date of September 29, 2029. Place of performance is Takoma Park, MD.
Description
To advance the development, evaluation, and predictive modeling of levonorgestrel intrauterine systems (LNG-iuss) by integrating accelerated testing, real-time release studies, microstructural analysis, and AI/ML-driven modeling approaches.
Quick answers
Who was awarded contract 75F40126C00059?
75F40126C00059 was awarded to University Of Connecticut by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.
How much is contract 75F40126C00059 worth?
The government has obligated $511,219 on 75F40126C00059. Its potential value, with all options, is $789,844.
Was contract 75F40126C00059 competed?
The extent of competition for 75F40126C00059 was full and open competition. The government received 257 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award